New study tackles stigma to curb meth use and boost PrEP in latino men

NCT ID NCT05784467

Not yet recruiting Knowledge-focused Sponsor: Arizona State University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a 12-week group program for HIV-negative Latino men who have sex with men and use methamphetamine. The program aims to help them cope with stigma, build resilience, and reduce meth use while also improving their interest in and use of PrEP, a medication that prevents HIV. The study will enroll 20 participants to see if the approach is feasible and promising.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: group behavioral intervention (12 weekly sessions on coping, resistance, and resilience)
What this could lead to: If successful, this could point toward a community-based approach to reduce meth use and increase HIV prevention among Latino men who have sex with men.
What could go wrong: This is a very small, early-stage study with only 20 participants, so results may not apply to larger groups. The program is intensive (12 weeks) and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS amphetamine abuse Social Stigma HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV METHAMPHETAMINE ABUSE SOCIAL STIGMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.